Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains-Reference-Cited by-同舟云学术

Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains

Published:2018-03-27 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Cheedarla Narayanaiah,Hemalatha Babu,Anangi Brahmaiah,Muthuramalingam Kannan,Selvachithiram Murugesan,Sathyamurthi Pattabiraman,Kailasam Nandagopal,Varadarajan Raghavan,Swaminathan Soumya,Tripathy Srikanth Prasad,Vaniambadi S. Kalyanaraman,Vadakkupattu D. Ramanathan,Hanna Luke Elizabeth

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference56 articles.

1. Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals;Cheedarla;Sci Rep,2017

2. Broadly neutralizing antibodies against HIV-1 as a novel aspect of the immune response;Shcherbakov;Acta Naturae,2015

3. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target;Walker;Science,2009

4. Broad neutralization coverage of HIV by multiple highly potent antibodies;Walker;Nature,2011

5. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses;Burton;Science,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals;Microbiology Spectrum;2022-12-21

2. Long-term and low-level envelope C2V3 stimulation from highly diverse virus isolates leads to frequent development of broad and elite antibody neutralization in HIV-1 infected individuals;2022-01-29

3. Early Presence of HIV-1 Subtype C in Washington, D.C.;AIDS Research and Human Retroviruses;2018-08